We are monitoring the impact of COVID-19 on Competent Cells Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3350
Share on
Share on

Global Competent Cells Market Analysis - By Type (Chemically, Electrocompetent), By Application (Cloning, Protein Expression, Other Applications), By End User (Pharmaceutical Companies, Academia), By Region – Industry Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: February, 2020
ID: 3350
Pages: 175

Industry Analysis

As per our research analysis, the global competent cells market was worth USD 1.7 billion in 2019. This value is estimated to grow at a CAGR of 10.40% and will reach USD 2.9 billion by 2024. The global Competent Cells market is developing at a rapid pace.

The cells which can proliferate are made competent to get faster results. The US FDA has approved new guidelines for the testing of retroviral vector-based human gene therapy for replication-competent retrovirus which will boost the research in the field of the competent cell as there is a more important requirement of retrovirus therapy and vaccine. The competent cell technique can be used to create a vaccine for retrovirus. The synthetic biology company SGI-DNA and Gibson Assembly Reagents have launched Vmax X2 competent cells. It is designed to generate two to four times more soluble protein in half of the time of current reliant on E. coli.

COVID-19 impact on the Competent Cells Market

In this time of COVID – 19 pandemic the competent cell technique can be used in the research as a bacterial artificial chromosome which is used to study the stature of coronavirus. It could boost the market growth of competent cell market. The countries in the Asia Pacific, such as India and China, are investing more in the research of competent cell technology.

MARKET DRIVERS

The competent cell market is driven by the increasing demand for recombinant DNA technique product. There are a large number of applications of recombinant DND technique such as in genes therapy, vaccine production, cancer treatment and treatment of retrovirus. The advancement in molecular engineering and growing research in therapeutic products which are used in the treatment of several diseases are likely to bolster the demand of the market.

MARKET RESTRAINTS

The high cost of research and the advance infrastructure required for the competent cell technique is restraining the demand of the competent cell market. These techniques require a skilled professional, and this is also slowing done the growth of the global competent cells market.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Type, Application and End-User

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This market research report on Global Competent Cells Market has been segmented and sub-segmented based on the type, application and end-user.

Competent Cells Market Analysis – By Type:

  • Chemically
  • Electrocompetent

Based on type, the chemically competent cells segment is expected to dominate the market in 2018. 

Competent Cells Market Analysis – By Application:

  • Cloning     
    • Subcloning & Routine Cloning
    • Phage Display Library Construction
    • Toxic/Unstable DNA Cloning
    • High-Throughput Cloning
  • Protein Expression              
  • Other Applications               
    • Mutagenesis
    • Large Plasmid Transformation
    • Single-Stranded DNA Production
    • Lentiviral Vector Production

Based on application, the Cloning is estimated to command the significant share of this market in 2019. Increasing study on cloning, driven by government funding is among the significant reasons driving market growth in this segment.

Competent Cells Market Analysis – By End User:

  • Pharmaceutical Companies
  • Academia

In 2019, the academic research segment held for the largest share of the market while the pharmaceutical companies segment is growing at an impressive CAGR.

Regional Analysis:

North America is estimated to constitute the largest share in the global competent cells market. At the same time, the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second-largest shareholder for the market during the forecast period.

Key market participants leading the Global Competent Cells Market profiled in this report are BioDynamics Laboratory, Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), Thermo Fisher Scientific, Inc. (the U.S), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Merck KGaA (Germany), Promega Corporation (U.S.), Bioline (U.K.) and Zymo Research (U.S.).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Chemically               

                                5.1.2 Electrocompetent

                                5.1.3  Y-o-Y Growth Analysis, By Type    

                                5.1.4  Market Attractiveness Analysis, By Type  

                                5.1.5  Market Share Analysis, ByType     

                5.2 Application                 

                                5.2.1 Cloning     

                                                5.2.1.1  Subcloning & Routine Cloning

                                                5.2.1.2 Phage Display Library Construction

                                                5.2.1.3 Toxic/Unstable Dna Cloning

                                                5.2.1.4 High-Throughput Cloning

                                5.2.2 Protein Expression              

                                5.2.3 Other Applications               

                                                5.2.3.1 Mutagenesis

                                                5.2.3.2 Large Plasmid Transformation

                                                5.2.3.4 Single-Stranded Dna Production

                                                5.2.3.5 Lentiviral Vector Production

                                5.2.7 Y-o-Y Growth Analysis, By Application         

                                5.2.8  Market Attractiveness Analysis, By Application      

                                5.2.9  Market Share Analysis, By Application       

                5.3 End User                      

                                5.3.1 Pharmaceutical Companies              

                                5.3.2 Academia

                                5.3.3 Y-o-Y Growth Analysis, By EndUser              

                                5.3.4  Market Attractiveness Analysis, By EndUser           

                                5.3.5  Market Share Analysis, By EndUser             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Application

                                                6.1.3.4 By EndUser

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Application

                                                6.1.4.4 By EndUser

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Application

                                                6.1.5.4 By EndUser

                6.2 North America                          

                                6.2.1 Introduction           

                                6.2.2 United States         

                                6.2.3 Canada     

                6.3 Europe                         

                                6.3.1 Introduction           

                                6.3.2 U.K             

                                6.3.3 Spain         

                                6.3.4 Germany 

                                6.3.5 Italy            

                                6.3.6 France       

                6.4 Asia-Pacific                 

                                6.4.1 Introduction           

                                6.4.2 China         

                                6.4.3 India          

                                6.4.4 Japan         

                                6.4.5 Australia   

                                6.4.6 South Korea           

                6.5 Latin America                             

                                6.5.1 Introduction           

                                6.5.2 Brazil          

                                6.5.3 Argentina

                                6.5.4 Mexico     

                                6.5.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.6.1 Introduction           

                                6.6.2 Middle-East            

                                6.6.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 BioDynamics Laboratory, Inc. (Japan)                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 GCC Biotech (India)                 

                8.3 SMOBIO Technology (Taiwan)                            

                8.4 Thermo Fisher Scientific, Inc. (U.S)                   

                8.5 QIAGEN N.V. (Germany)                      

                8.6 OriGene Technologies (U.S.)                              

                8.7 Merck KGaA (Germany)                       

                8.8 Promega Corporation (U.S.)                

                8.9 Bioline (U.K.)                             

                8.10 Zymo Research (U.S.)                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Competent cells Market By Region, From 2019-2024 ( USD Million )
  2. Global Competent cells Market By Type, From 2019-2024 ( USD Million )
  3. Global Chemically Market By Region, From 2019-2024 ( USD Million )
  4. Global Electro Competent Market By Region, From 2019-2024 ( USD Million )
  5. Global Competent cells Market By Application, From 2019-2024 ( USD Million )
  6. Global SubCloning Market By Region, From 2019-2024 ( USD Million )
  7. Global Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  8. Global Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  9. Global High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  10. Global  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  11. Global Competent cells Market By End User, From 2019-2024 ( USD Million )
  12. Global Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  13. Global Academia Market By Region, From 2019-2024 ( USD Million )
  14. North America Competent cells Market By Type, From 2019-2024 ( USD Million )
  15. North America Chemically Market By Region, From 2019-2024 ( USD Million )
  16. North America Electro Competent Market By Region, From 2019-2024 ( USD Million )
  17. North America Competent cells Market By Application, From 2019-2024 ( USD Million )
  18. North America SubCloning Market By Region, From 2019-2024 ( USD Million )
  19. North America Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  20. North America Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  21. North America High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  22. North America  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  23. North America Competent cells Market By End User, From 2019-2024 ( USD Million )
  24. North America Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  25. North America Academia Market By Region, From 2019-2024 ( USD Million )
  26. United States Competent cells Market By Type, From 2019-2024 ( USD Million )
  27. United States Competent cells Market By Application, From 2019-2024 ( USD Million )
  28. United States Competent cells Market By End User, From 2019-2024 ( USD Million )
  29. Canada Competent cells Market By Type, From 2019-2024 ( USD Million )
  30. Canada Competent cells Market By Application, From 2019-2024 ( USD Million )
  31. Canada Competent cells Market By End User, From 2019-2024 ( USD Million )
  32. Europe Competent cells Market By Type, From 2019-2024 ( USD Million )
  33. Europe Chemically Market By Region, From 2019-2024 ( USD Million )
  34. Europe Electro Competent Market By Region, From 2019-2024 ( USD Million )
  35. Europe Competent cells Market By Application, From 2019-2024 ( USD Million )
  36. Europe SubCloning Market By Region, From 2019-2024 ( USD Million )
  37. Europe Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  38. Europe Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  39. Europe High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  40. Europe  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  41. Europe Competent cells Market By End User, From 2019-2024 ( USD Million )
  42. Europe Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  43. Europe Academia Market By Region, From 2019-2024 ( USD Million )
  44. U.K. Competent cells Market By Type, From 2019-2024 ( USD Million )
  45. U.K. Competent cells Market By Application, From 2019-2024 ( USD Million )
  46. U.K. Competent cells Market By End User, From 2019-2024 ( USD Million )
  47. Germany Competent cells Market By Type, From 2019-2024 ( USD Million )
  48. Germany Competent cells Market By Application, From 2019-2024 ( USD Million )
  49. Germany Competent cells Market By End User, From 2019-2024 ( USD Million )
  50. France Competent cells Market By Type, From 2019-2024 ( USD Million )
  51. France Competent cells Market By Application, From 2019-2024 ( USD Million )
  52. France Competent cells Market By End User, From 2019-2024 ( USD Million )
  53. Italy Competent cells Market By Type, From 2019-2024 ( USD Million )
  54. Italy Competent cells Market By Application, From 2019-2024 ( USD Million )
  55. Italy Competent cells Market By End User, From 2019-2024 ( USD Million )
  56. Spain Competent cells Market By Type, From 2019-2024 ( USD Million )
  57. Spain Competent cells Market By Application, From 2019-2024 ( USD Million )
  58. Spain Competent cells Market By End User, From 2019-2024 ( USD Million )
  59. Asia-Pacific Competent cells Market By Type, From 2019-2024 ( USD Million )
  60. Asia-Pacific Chemically Market By Region, From 2019-2024 ( USD Million )
  61. Asia-Pacific Electro Competent Market By Region, From 2019-2024 ( USD Million )
  62. Asia-Pacific Competent cells Market By Application, From 2019-2024 ( USD Million )
  63. Asia-Pacific SubCloning Market By Region, From 2019-2024 ( USD Million )
  64. Asia-Pacific Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  65. Asia-Pacific Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  66. Asia-Pacific High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  67. Asia-Pacific  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  68. Asia-Pacific Competent cells Market By End User, From 2019-2024 ( USD Million )
  69. Asia-Pacific Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  70. Asia-Pacific Academia Market By Region, From 2019-2024 ( USD Million )
  71. Japan Competent cells Market By Type, From 2019-2024 ( USD Million )
  72. Japan Competent cells Market By Application, From 2019-2024 ( USD Million )
  73. Japan Competent cells Market By End User, From 2019-2024 ( USD Million )
  74. China Competent cells Market By Type, From 2019-2024 ( USD Million )
  75. China Competent cells Market By Application, From 2019-2024 ( USD Million )
  76. China Competent cells Market By End User, From 2019-2024 ( USD Million )
  77. India Competent cells Market By Type, From 2019-2024 ( USD Million )
  78. India Competent cells Market By Application, From 2019-2024 ( USD Million )
  79. India Competent cells Market By End User, From 2019-2024 ( USD Million )
  80. Australia Competent cells Market By Type, From 2019-2024 ( USD Million )
  81. Australia Competent cells Market By Application, From 2019-2024 ( USD Million )
  82. Australia Competent cells Market By End User, From 2019-2024 ( USD Million )
  83. South Korea Competent cells Market By Type, From 2019-2024 ( USD Million )
  84. South Korea Competent cells Market By Application, From 2019-2024 ( USD Million )
  85. South Korea Competent cells Market By End User, From 2019-2024 ( USD Million )
  86. Latin America Competent cells Market By Type, From 2019-2024 ( USD Million )
  87. Latin America Chemically Market By Region, From 2019-2024 ( USD Million )
  88. Latin America Electro Competent Market By Region, From 2019-2024 ( USD Million )
  89. Latin America Competent cells Market By Application, From 2019-2024 ( USD Million )
  90. Latin America SubCloning Market By Region, From 2019-2024 ( USD Million )
  91. Latin America Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  92. Latin America Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  93. Latin America High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  94. Latin America  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  95. Latin America Competent cells Market By End User, From 2019-2024 ( USD Million )
  96. Latin America Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  97. Latin America Academia Market By Region, From 2019-2024 ( USD Million )
  98. Brazil Competent cells Market By Type, From 2019-2024 ( USD Million )
  99. Brazil Competent cells Market By Application, From 2019-2024 ( USD Million )
  100. Brazil Competent cells Market By End User, From 2019-2024 ( USD Million )
  101. Argentina Competent cells Market By Type, From 2019-2024 ( USD Million )
  102. Argentina Competent cells Market By Application, From 2019-2024 ( USD Million )
  103. Argentina Competent cells Market By End User, From 2019-2024 ( USD Million )
  104. Mexico Competent cells Market By Type, From 2019-2024 ( USD Million )
  105. Mexico Competent cells Market By Application, From 2019-2024 ( USD Million )
  106. Mexico Competent cells Market By End User, From 2019-2024 ( USD Million )
  107. Rest of Latin America Competent cells Market By Type, From 2019-2024 ( USD Million )
  108. Rest of Latin America Competent cells Market By Application, From 2019-2024 ( USD Million )
  109. Rest of Latin America Competent cells Market By End User, From 2019-2024 ( USD Million )
  110. Middle East & Africa Competent cells Market By Type, From 2019-2024 ( USD Million )
  111. Middle East & Africa Chemically Market By Region, From 2019-2024 ( USD Million )
  112. Middle East & Africa Electro Competent Market By Region, From 2019-2024 ( USD Million )
  113. Middle East & Africa Competent cells Market By Application, From 2019-2024 ( USD Million )
  114. Middle East & Africa SubCloning Market By Region, From 2019-2024 ( USD Million )
  115. Middle East & Africa Phage Display Library Production Market By Region, From 2019-2024 ( USD Million )
  116. Middle East & Africa Unstable DNA Cloning Market By Region, From 2019-2024 ( USD Million )
  117. Middle East & Africa High-Throughput Cloning Market By Region, From 2019-2024 ( USD Million )
  118. Middle East & Africa  Mutagenesis Market By Region, From 2019-2024 ( USD Million )
  119. Middle East & Africa Competent cells Market By End User, From 2019-2024 ( USD Million )
  120. Middle East & Africa Pharmaceutical Companies Market By Region, From 2019-2024 ( USD Million )
  121. Middle East & Africa Academia Market By Region, From 2019-2024 ( USD Million )
  122. Middle East Competent cells Market By Type, From 2019-2024 ( USD Million )
  123. Middle East Competent cells Market By Application, From 2019-2024 ( USD Million )
  124. Middle East Competent cells Market By End User, From 2019-2024 ( USD Million )
  125. Africa Competent cells Market By Type, From 2019-2024 ( USD Million )
  126. Africa Competent cells Market By Application, From 2019-2024 ( USD Million )
  127. Africa Competent cells Market By End User, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample